OverviewChartNewsTraderScreen

Bellicum Pharmaceuticals/  US0794814048  /

IEX
2023-05-31  9:47:30 PM Chg. - Volume Bid- Ask- High Low
0.68USD - 305
Turnover: 206.30		 -Bid Size: - -Ask Size: - 0.68 0.67
GlobeNewswire 01-17 Day One Announces Two New Appointments to Board of Directors
GlobeNewswire 01-08 NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Tran...
GlobeNewswire 2022-03-24 Bellicum Reports Fourth Quarter 2021 Financial Results and Provides Operational Update
GlobeNewswire 2022-01-26 Bellicum Pharmaceuticals to Participate in the B. Riley Securities 2022 Virtual Oncology Conference
GlobeNewswire 2021-12-13 Bellicum Regains Compliance with Nasdaq Continued Listing Requirements
GlobeNewswire 2021-12-06 Bellicum Announces Positive Interim Data from Phase 1/2 GoCAR-T® Studies, Secures $35 Million Privat...
GlobeNewswire 2021-11-04 Bellicum Reports Third Quarter 2021 Financial Results and Provides Operational Update
GlobeNewswire 2021-09-13 Day One Appoints Jaa Roberson as Chief People Officer
GlobeNewswire 2021-09-03 Bellicum Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment Confere...
GlobeNewswire 2021-09-01 Cidara Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Financial Officer and Chief Business...
GlobeNewswire 2021-09-01 Bellicum and MD Anderson Announce Additional License Agreement for Use of CaspaCIDe® Safety Switch
GlobeNewswire 2021-08-26 Imagin Medical Secures New $3 Million Convertible Note Financing
GlobeNewswire 2021-08-12 Bellicum Reports Second Quarter 2021 Financial Results and Provides Operational Update
GlobeNewswire 2021-07-26 Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2021-06-28 Bellicum Enters License Agreement with UNC Lineberger and Mass General for Use of CaspaCIDe® Safety ...
GlobeNewswire 2021-06-01 Invectys nominates Rosemary Williams, CPA, as Vice-President for Administration and Controller
GlobeNewswire 2021-05-17 Bellicum Reports First Quarter 2021 Financial Results and Provides Operational Update
GlobeNewswire 2021-03-30 Bellicum Reports Fourth Quarter 2020 Financial Results and Provides Operational Update
GlobeNewswire 2021-03-23 Bellicum to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
GlobeNewswire 2021-03-04 Bellicum Announces First Reported Use of CaspaCIDe® Safety Switch to Mitigate CAR-T Cell Toxicity
GlobeNewswire 2021-03-01 Corcept Therapeutics Expands Executive Team; Atabak Mokari Joins As Chief Financial Officer; Charles...
GlobeNewswire 2021-01-28 Bellicum Reports FDA Lifted Clinical Hold on BPX-601 Phase 1/2 Clinical Trial
GlobeNewswire 2020-12-10 Bellicum Enrolls First Patient in Phase 1/2 Clinical Trial for BPX-603
GlobeNewswire 2020-12-07 Bellicum Reports Clinical Hold Placed on BPX-601 Phase 1/2 Clinical Trial
GlobeNewswire 2020-11-05 Bellicum Reports Third Quarter 2020 Financial Results and Provides Operational Update